Can kappa free light chains simplify multiple sclerosis diagnostics for laboratories?
New laboratory tools are prompting a rethink of how intrathecal inflammation is assessed beyond oligoclonal bands
New laboratory tools are prompting a rethink of how intrathecal inflammation is assessed beyond oligoclonal bands
New, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks
Thermo Fisher Scientific launches Registry to advance real-world evidence in neurodegenerative care
DNA-free nucleic acid isolation kits streamline molecular diagnostics, improving sensitivity, speed, and automation for early diagnosis and monitoring
Dr. Lauren Murphy at the University of Oxford is investigating how platelets could hold the key to detecting cancer in patients with minimal residual disease
Discover how automation enhances accuracy and efficiency of liquid biopsy workflows, paving the way for advancements in personalized medicine and improved patient care
Froedtert Hospital results reinforce growing real-world evidence that IntelliSep is a transformative tool for suspected infections in emergency departments
The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
President of Diagnostic Solutions at Hologic explains how adopting advanced molecular‑diagnostic technologies is for labs of the future
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea
The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe
Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape
The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis
Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds
University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025
The point-of-care test detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity
Test helps to identify patients at high risk who need intervention or closer monitoring
Stanford Cancer Center South Bay streamlines chemistry test delivery with CLSI AUTO15, boosting lab efficiency and patient care
Part two of the Quality Data, Informed Action webinar series explores how informatics and essential quality indicators can enhance patient safety
Our one day social media takeover on Linkedin
Dr. Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize
Take the survey and submit a guest editorial
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy